PTAC/CFTR
Martin Mense
CFFT Lab, Cystic Fibrosis Foundation
Marianne Carlon
KU Leuven
This symposium aims to increase the awareness and understanding of the substantial challenges to delivering effective genetic therapies to persons with CF. From a review of the anatomy of the lung and airways, including extracellular barriers that need to be navigated by aerosol or intravenous delivery technologies, the presentations will become increasingly more granular. Airway cell types will be discussed that need to be targeted by transient therapies, like CFTR mRNA or ASOs, or permanent curative therapies. The last two presentations will describe the two key intracellular challenges, endosomal escape and delivery to the nucleus, and approaches to overcoming these barriers will be proposed.
Speaker: David K. Meyerholz, DVM, PhD, Dipl. ACVP & ACVM (he/him/his) – The University of Iowa
Speaker: Brigitte Gomperts, MD (she/her/hers) – UCLA
Speaker: Anders Wittrup, MD, PhD – Lund University
Speaker: Millie Sullivan, PhD (she/her/hers) – University of Delaware